MammoGene Sàrl provides medical consultations to assess an individual’s risk of breast and ovarian cancer. Assessments are typically dual consultations combining a gynecologist and a geneticist, use validated risk-calculation tools, and may include recommendations for genetic testing, a written report and guidance on surveillance or preventive measures.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Risk assessment consultation including family and gynaecological history, calculation of the risk of occurrence, discussion of preventive measures, and provision of a report.
Oncogenetic consultation
Joint consultation by a gynaecologist and a geneticist, with genetic counselling, assessment of mutation risk, and referral for genetic analyses if indicated.
Prescription and coordination of genetic analyses
Organisation of genetic tests based on a blood analysis, with a letter to the medical adviser, request for reimbursement, and partner laboratory.
Risk management and prevention measures
Advice on surveillance, drug-based or surgical prevention depending on the risk level or the presence of deleterious mutations.
Information and documentation on breast cancer risk
Doctor and patient brochures, explanatory articles on risk factors, risk models, genetic tests, and reimbursement.
Knowledge
No knowledge articles yet
Once MammoGene Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.